New p53 mutations in hilar cholangiocarcinoma

European Journal of Clinical Investigation

Volumn 30, Issue 9, 2000, Pages 798-803

  Tullo, ^a,b,c   D'Erchia, ^a,b,c   Honda, ^a,b,c   Kelly, ^a,b,c   Habib, ^a,b,c   Saccone, ^a,b,c   Sbisa ^a,b,c  

^a CNR   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cholangiocarcinoma; Liver carcinoma; Mutation; P53; Sequencing; Tumour suppressor gene

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ENVIRONMENTAL FACTOR; EUROPE; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION MAPPING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033821601     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00717.x     Document Type: Article

References (27)

1. Hilar cholangiocarcinoma
2. Malignancies of the biliary tree
3. Oncogene expression in cholangiocarcinoma and in normal hepatic development
4. Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand
5. Clinical implications of the p53 tumor-suppressor gene
6. The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis
7. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents
8. p53 mutagenesis in Klatskin tumors
9. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high- incidence area
10. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients
11. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
12. Mutational analysis of the p53 and K-ras genes and allelo-type study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas
13. Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancers
14. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma
15. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
16. Characterization of p53 mutations in Colorectal Liver Metastases and correlation with clinical parameters
17. Mutation of p53 tumour suppressor gene in Hepatocellular Carcinoma
18. Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms
19. Cloning and sequence of a processed p53 pseudogene from rat: A potential source of false 'mutations' in PCR fragments of tumor DNA
20. Mutagenesis of codon 248 of the human p53 tumor suppressor gene by N-ethyl-N-nitrosourea
21. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis (2-hydroxypropyl) amine
22. Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in B6D2F1 mice
23. Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation
24. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
25. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
26. A new taqi polymorphism p53 gene